deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT01147601

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas: A Prospective Double Blinded Placebo Controlled Study

Sponsor: Oregon Health and Science University

Conditions Hemangioma Infant
Interventions Control (placebo) group topical 0.5% Timolol
Updated 9 times since 2017 Last updated: Apr 19, 2017 Started: Mar 31, 2010 Primary completion: Oct 31, 2012 Completion: Aug 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Oregon Health and Science University

See all terminations from Oregon Health and Science University

Other Hemangioma trials with similar outcome

Browse all Hemangioma trials

Listed as NCT01147601, this EARLY_PHASE1 trial focuses on Hemangioma and Infant and remains terminated or withdrawn. Sponsored by Oregon Health and Science University, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotUnknown Status~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated EARLY_PHASE1

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated EARLY_PHASE1

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated EARLY_PHASE1

  2. Aug 2017 — Jun 2018 [monthly]

    Terminated EARLY_PHASE1

    Status: Unknown Status → Terminated

  3. Feb 2017 — Aug 2017 [monthly]

    Unknown Status EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

  4. Jan 2017 — Feb 2017 [monthly]

    Unknown Status Phase 0

    First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oregon Health and Science University
Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations